VulnCheck
VulnCheck is a cybersecurity company providing vulnerability, exploit, and initial access intelligence to help organizations prioritize and respond to threats.
Secondary Market Price
Secondary Market Price
How VulnCheck Measures Up
To help you manage your VulnCheck equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still gathering data to finalize our rating for VulnCheck. Check back shortly for our projection of its value four years from now.
Exit Risk
TBD
We are still gathering data on VulnCheck to train our machine learning model. Check back soon for our exit risk rating for VulnCheck!
Funding Stage
Series A
Since VulnCheck is in its Series A stage, it means they've established a solid foundation and are now focused on significant growth. As an employee, you'd be joining at a pivotal time where you can make a real impact but with more stability than an early-stage startup.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of VulnCheck's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future VulnCheck Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for VulnCheck's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
VulnCheck is a cybersecurity company that develops a threat intelligence platform focused on exploit and vulnerability data. The company provides services including Vulnerability Intelligence, Exploit Intelligence, and Initial Access Intelligence to help organizations predict avenues of attack and prioritize remediation efforts. Founded in 2021 by Anthony Bettini, the former Head of Research at Tenable, VulnCheck is headquartered in Lexington, Massachusetts. Its platform is designed to deliver machine-consumable data that integrates into clients' existing security tools and systems.
The company has reported significant recent developments, including raising a $12 million Series A funding round in 2025, led by Ten Eleven Ventures. VulnCheck also announced it had surpassed $10 million in Annual Recurring Revenue and increased its headcount by 126% in 2025. As a real-world example of its work, the company's research team identified and published details on the active exploitation of a critical XWiki vulnerability (CVE-2025-24893), providing defenders with concrete indicators such as attacker IP addresses and file hashes. In recognition of its work, VulnCheck was named a SINET16 Innovation Award winner.
- Sorenson Capital
- Ten Eleven
- Founder, CEO Anthony Bettini
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is VulnCheck worth joining?
Deciding whether to join VulnCheck depends on your personal career goals and an assessment of their overall compensation package. Tools like Prospect can help you understand the potential future value of your equity grant, which is a critical part of the decision.
What should I do with my VulnCheck stock?
Managing your VulnCheck stock effectively requires a strategy for exercising options and planning for taxes to maximize its value. Platforms like Prospect offer tools to create customized plans for your equity, helping you decide when to act.
Can you sell VulnCheck stock?
As a private company, selling VulnCheck stock is typically possible during specific liquidity events like tender offers or on secondary markets. Equity management platforms can help you navigate these opportunities and determine the most tax-optimal shares to sell.
How can I find the value of my VulnCheck stock?
The value of private stock is often determined by the company's latest 409A valuation, but this doesn't reflect its full market potential. To better understand its future worth, you can use platforms like Prospect, which use predictive models to forecast your equity's value.
What is VulnCheck's equity worth?
The precise worth of a private company's equity isn't public and changes based on performance, funding rounds, and market conditions. You can model the potential future value of your specific VulnCheck holdings using specialized financial tools that analyze various scenarios.
What is VulnCheck's stock ticker symbol?
VulnCheck is a private company, so it does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell VulnCheck stock?
Trading stock in a private company like VulnCheck is restricted and typically occurs on secondary markets or through company-sanctioned tender offers. Platforms like Prospect provide tools to help employees navigate selling opportunities and optimize their transactions for taxes.
What is the criteria to buy or invest in VulnCheck stock?
Investing in a private company like VulnCheck is generally limited to institutional investors or accredited investors through secondary markets. For most individuals, the primary way to acquire stock is by being an employee who receives equity compensation as part of their pay.
